Latest Cytokines Stories
XenoTech awarded US Patent for "In Vitro Test System to Evaluate Xenobiotics as Immune-Modulators of Drug Transport and Metabolism in Human Hepatocytes". Lenexa,
Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,
- In adult patients co-infected with genotype 1 (GT1) hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) type 1 infection, TURQUOISE-I demonstrated sustained virologic response
-- Studies focused on patients where there is a high unmet need today or anticipated in the near future -- BOSTON, Nov.
Data from 25 accepted abstracts include results from: NORTH CHICAGO, Ill., Oct.
MarketOptimizer.org adds “PharmaPoint: Hepatitis C Virus – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update” to its store.
- Data include post-hoc assessments of controlled studies in relapsing MS regarding evolution of gadolinium-enhancing lesions, assessments of predictive scores for disease activity and disability progression,
~Convening World's Leading Researchers in MS with a Program Covering all Aspects of Research Including Cause and Pathology, Genetics and Environmental Impact, Emerging Treatment Study Findings and
FLINT, Mich., Sept.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.